Website stats for Morphosys - morphosys.de
Kontakt Adresse MorphoSys AG Semmelweisstr. Planegg Deutschland Phone: + - Fax: + - E-Mail: [email protected] MorphoSys US Inc.
It has a alexa rank of #1,312,940 in the world. It is a domain having .de extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, morphosys.de is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 668 |
| Daily Pageviews: | 1,336 |
Estimated Valuation
| Income Per Day: | $ 4.00 |
| Estimated Worth: | $ 960.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | 5,030 |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | 147,000 |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,312,940 |
| PageSpeed Score: | 65 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
188.40.105.138
Hosted Country:
DE
Location Latitude:
49.4478Location Longitude:
11.0683Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For morphosys.de
MorphoSys AG
MorphoSys veröffentlicht Ergebnisse für die ersten neun Monate und das...
MorphoSys AG
MorphoSys mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer.
MorphoSys Celebrates 25th Anniversary | MorphoSys AG
Jul 06, 2017 · MorphoSys is committed to developing exceptional new treatments for patients suffering from serious diseases. The biotechnology company was founded in summer of...
MorphoSys - Planegg | Facebook
MorphoSys, Planegg. 286 likes. Our mission is to make exceptional innovative biopharmaceuticals to improve lives of patients suffering serious diseases.
MORPHOSYS (DE:MOR) Valuation Analysis - Macroaxis
MORPHOSYS Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as...
Current MORPHOSYS (DE:MOR2) Technical Analysis - Macroaxis
As of the 4th of December, MORPHOSYS secures the mean deviation of 1.85, and Risk Adjusted Performance of (0.10).In respect to fundamental indicators, the technical analysis...
Senior Management Group der MorphoSys AG | MorphoSys ...
Dr. Claudia Gutjahr-Löser Head of Corporate Communications & Investor Relations. Dr. Steffen Heeger Head of Clinical Development. Dr. Bernd Hutter Head of Intellectual Property
Imprint | MorphoSys Annual Report 2015
Lena-Christ-Str. 48 82152 Martinsried/Planegg Germany Phone:: +49-89-89927-0 Fax: +49-89-89927-222 Email: [email protected] www.morphosys.de. CORPORATE COMMUNICATIONS AND...
Job opportunities | MorphoSys AG
You are leaving morphosys.com and will be transferred to the MorphoSys US website which is intended for US residents.
DGAP-News: MorphoSys AG: Thomas Biegi leitet die ...
Dec 01, 2020 · DGAP-News: MorphoSys AG / Schlagwort(e): Sonstiges Thomas Biegi leitet die Unternehmenskommunikation bei MorphoSys 01.12.2020 / 22:02 Für …
Morphosys – Wikipedia
Die MorphoSys AG ist ein 1992 gegründetes biopharmazeutisches Unternehmen mit Sitz in Planegg in der Nähe von München.Zur Gesellschaft gehört eine hundertprozentige...
MorphoSys | Facebook
We are very happy to announce that today MorphoSys and Incyte have entered into a collaboration and license agreement.. The partnership brings together MorphoSys’ strong...
Morphosys Ag - Martinsried/planegg 82152 (Landkreis ...
* This phone number available for 3 min is not the recipient’s number but a number from a service which will put you through to that person. This service is produced by Kompass.
MorphoSys AG, MPSYF:PKC profile - FT.com
Year on year MorphoSys AG 's revenues fell -6.13% from 76.44m to 71.76m. This along with an increase in selling, general and administrative costs has contributed to a reduction...
MORPHOSYS AG O.N. (MOR.DE) Aktienpreis, Nachrichten, Kurs ...
Weitere Informationen unter www.morphosys.de. Monjuvi(R) und CyCAT(R) sind eingetragene Warenzeichen der MorphoSys AG. Tremfya(R) ist ein eingetragenes Warenzeichen von Janssen...
MorphoSys AG, MOR:HAN profile - FT.com
MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation...
Org Chart Morphosys - The Official Board
Oct 01, 2020 · The org chart of Morphosys contains its 39 main executives including Jean-Paul Kress, Jens Holstein and Malte Peters.
Nachrichten & Diskussionen zu Morphosys
Aktuelle Nachrichten & Diskussionen aus dem w:o Forum zu Morphosys | 663200. Seien Sie informiert.
DGAP-News: MorphoSys AG: MorphoSys' Lizenzpartner gibt die ...
Dec 02, 2020 · Weitere Informationen unter https://www.morphosys.de. Monjuvi (R) und HuCAL (R) sind eingetragene Warenzeichen der MorphoSys AG Tremfya (R) ist ein eingetragenes...
MorphoSys AG - Planegg - jobvector
MorphoSys’s mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Innovative technologies and smart...
MORPHOSYS AKTIE | Aktienkurs | Kurs | (663200,DE0006632003)
MORPHOSYS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie MorphoSys | 663200 | DE0006632003
MORG.DE - MorphoSys AG Profile | Reuters
About MorphoSys AG. MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and …
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 1 |
| H3 Headings: | Not Applicable | H4 Headings: | 3 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 4 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Zur Mitteilung | 10 | 2.105 % | No |
| Medien und | 4 | 0.842 % | No |
| MorphoSys US | 3 | 0.632 % | No |
| MorphoSys und | 3 | 0.632 % | No |
| MorphoSys AG | 3 | 0.632 % | No |
| und Incyte | 3 | 0.632 % | No |
| 49 89 | 2 | 0.421 % | No |
| auf Twitter | 2 | 0.421 % | No |
| 89 899 | 2 | 0.421 % | No |
| US Inc | 2 | 0.421 % | No |
| und Investoren | 2 | 0.421 % | No |
| Medien InformationenHauptmenü | 2 | 0.421 % | No |
| Business Development | 2 | 0.421 % | No |
| COVID19 auf | 2 | 0.421 % | No |
| 13012020 MorphoSys | 2 | 0.421 % | No |
| Mitteilung 13012020 | 2 | 0.421 % | No |
| für Tafasitamab | 2 | 0.421 % | No |
| um so | 2 | 0.421 % | No |
| Incyte unterzeichnen | 2 | 0.421 % | No |
| unterzeichnen globalen | 2 | 0.421 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| innovative biopharmazeutische Medikamente zu | 2 | 0.421 % | No |
| biopharmazeutische Medikamente zu entwickeln | 2 | 0.421 % | No |
| und innovative biopharmazeutische Medikamente | 2 | 0.421 % | No |
| herausragende und innovative biopharmazeutische | 2 | 0.421 % | No |
| ist es herausragende und | 2 | 0.421 % | No |
| es herausragende und innovative | 2 | 0.421 % | No |
| Medikamente zu entwickeln um | 2 | 0.421 % | No |
| zu entwickeln um so | 2 | 0.421 % | No |
| das Leben schwerkranker Patienten | 2 | 0.421 % | No |
| Leben schwerkranker Patienten zu | 2 | 0.421 % | No |
| so das Leben schwerkranker | 2 | 0.421 % | No |
| um so das Leben | 2 | 0.421 % | No |
| entwickeln um so das | 2 | 0.421 % | No |
| Mission ist es herausragende | 2 | 0.421 % | No |
| Unsere Mission ist es | 2 | 0.421 % | No |
| MorphoSys und Incyte unterzeichnen | 2 | 0.421 % | No |
| und Incyte unterzeichnen globalen | 2 | 0.421 % | No |
| Auswirkungen von COVID19 auf | 2 | 0.421 % | No |
| von COVID19 auf den | 2 | 0.421 % | No |
| Zur Mitteilung 13012020 MorphoSys | 2 | 0.421 % | No |
Mobile Friendly Check
Mobile Friendly : Yes
Score : 98
Mobile viewport not set: 0
Text too small to read: 0
Uses incompatible plugins: 0
Content wider than screen: 0
Links too close together: 1.23779296875
CMS: DRUPAL
Locale: en_US
Roboted Resources: 0
Transient Fetch Failure Resources: 0
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Wed, 08 Apr 2020 17:03:34 GMT
Server: Apache
Strict-Transport-Security: max-age=31536000; includeSubDomains
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
X-Drupal-Cache: HIT
Etag: "1586360352-1"
Content-Language: de
X-Generator: Drupal 7 (http://drupal.org)
Link:
Cache-Control: public, max-age=3600
Last-Modified: Wed, 08 Apr 2020 15:39:12 GMT
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Cookie,Accept-Encoding
Content-Encoding: gzip
Access-Control-Allow-Origin: *
X-UA-Compatible: IE=Edge
Transfer-Encoding: chunked
Content-Type: text/html; charset=utf-8
Domain Information
| Domain Registrar: |
DENIC eG
|
|---|---|
| Last Modified: | 2019-10-29 4 years 6 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns.udag.de | |
192.174.68.8 |  Austria |
| ns.udag.net | |
176.97.158.8 | Austria |
| ns.udag.org | |
176.97.158.91 | Austria |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| morphosys.de | A | 589 |
IP: 188.40.105.138 |
| morphosys.de | NS | 86400 |
Target: ns.udag.net |
| morphosys.de | NS | 86400 |
Target: ns.udag.org |
| morphosys.de | NS | 86400 |
Target: ns.udag.de |
| morphosys.de | SOA | 600 |
MNAME: ns.udag.de RNAME: hostmaster.united-domains.de Serial: 2019102401 Refresh: 10800 Retry: 3600 Expire: 604800 |
| morphosys.de | MX | 3600 |
Target: mx01.morphosys.com |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
%
% Terms and Conditions of
Use
%
% The above data may only be used within the scope of
technical or
% administrative necessities of Internet operation or
to remedy legal
% problems.
% The use for other purposes, in
particular for advertising, is not permitted.
%
% The DENIC
whois service on port 43 doesn't disclose any information
concerning
% the domain holder, general request and abuse
contact.
% This information can be obtained through use of our
web-based whois service
% available at the DENIC website:
%
http://www.denic.de/en/domains/whois-service/web-whois.html
%
%
Domain: morphosys.de
Nserver: ns.udag.de
Nserver:
ns.udag.net
Nserver: ns.udag.org
Status: connect
Changed:
2019-10-28T18:01:31+01:00
Similarly Ranked Websites
Scientific Minds - Online Science Education Programs for K-12,...
Scientific Minds is a publisher of technology-based science education products built from state standards. Our product development is based on research proving that students...
1,312,960 
$ 960.00
Voyage sur mesure, sejour de luxe, autotour - Voyageurs du Monde
Voyageurs du Monde : agence de voyage spécialiste des voyages sur mesure. Consultez toutes nos offres de séjours à la carte, week-ends de charme, autotours, croisières de luxe…...
1,312,962 $ 960.00